Literature DB >> 32885882

A serine loop in tissue factor mediates substrate selectivity by the tissue factor-factor VIIa complex.

Fabienne Birkle1, James H Morrissey1,2.   

Abstract

Essentials How the tissue factor-factor VIIa complex selects between different substrates is not well understood. We investigated a serine loop in tissue factor and its role in substrate selectivity. The tissue factor serine loop is selective for factor X over factor IX. Substrate selectivity is facilitated by differential regulation of the nearby tissue factor exosite. ABSTRACT: Background The tissue factor-factor VIIa (TF-FVIIa) complex is the physiologic activator of blood clotting and plays a major role in many thrombotic diseases. TF-FVIIa drives clotting through proteolytic cleavage of its major protein substrates, factor IX (FIX) and factor X (FX). However, it remains unclear how TF-FVIIa exhibits selectivity between these substrates. We previously showed that TF residues adjacent to the putative substrate binding site of TF ("exosite") facilitate FX activation, but the role of these residues in substrate selectivity had not been tested. Objectives We hypothesized that a TF serine loop (residues S160-S163) mediates substrate selectivity by the TF-FVIIa complex. Methods We generated TF serine loop and exosite mutants. The mutants were tested in FIX and FX enzyme activation assays as well as thrombin generation assays. Results Changes in the length of the serine loop affected rates of FIX and FX activation very differently. FX activation was decreased by up to 200-fold when the loop length was changed by just one residue. In contrast, FIX activation was largely unaffected. Substrate selectivity was also detected in thrombin generation assays. Activation assays with TF serine loop and exosite double mutants revealed that the serine loop has no effect on the exosite during FIX activation. In contrast, the serine loop regulates the exosite during FX activation. Conclusions Our results provide new insights into how the TF-FVIIa complex actively selects between its major protein substrates, which is mediated by a TF serine loop.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  factor IX; factor X; serine; thrombosis; tissue factor

Mesh:

Substances:

Year:  2020        PMID: 32885882      PMCID: PMC7790960          DOI: 10.1111/jth.15087

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  31 in total

1.  Restoring full biological activity to the isolated ectodomain of an integral membrane protein.

Authors:  Emily K Waters; James H Morrissey
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

2.  Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.

Authors:  S Dittmar; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.

Authors:  Y Z Ohkubo; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2010-02-24       Impact factor: 5.824

4.  Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.

Authors:  R J Baugh; C D Dickinson; W Ruf; S Krishnaswamy
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

5.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Authors:  J N Wilcox; K M Smith; S M Schwartz; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: importance of amino acid residue K192.

Authors:  P F Neuenschwander; J H Morrissey
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

7.  Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism.

Authors:  P F Neuenschwander; M M Fiore; J H Morrissey
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

Review 8.  Tissue factor: a key molecule in hemostatic and nonhemostatic systems.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

9.  Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.

Authors:  P F Neuenschwander; E Bianco-Fisher; A R Rezaie; J H Morrissey
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

10.  Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.

Authors:  T J Girard; L A MacPhail; K M Likert; W F Novotny; J P Miletich; G J Broze
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

View more
  2 in total

1.  How the tissue factor-VIIa complex keeps two substrates in the loop.

Authors:  Sol Schulman
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

2.  A systematic approach for evaluating the role of surface-exposed loops in trypsin-like serine proteases applied to the 170 loop in coagulation factor VIIa.

Authors:  Anders B Sorensen; Per Jr Greisen; Jesper J Madsen; Jacob Lund; Gorm Andersen; Pernille G Wulff-Larsen; Anette A Pedersen; Prafull S Gandhi; Michael T Overgaard; Henrik Østergaard; Ole H Olsen
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.